Myokardia, Inc is a global biopharmaceutical company headquartered in Brisbane, CA. They are dedicated to developing innovative medicines to transform the lives of patients, with a particular focus on oncology and immunology. With a strong commitment to research and development, Myokardia strives to pioneer groundbreaking treatments and improve patient outcomes. Their diverse portfolio of medicines and strategic partnerships position them as a leader in the biopharmaceutical industry.
Driven by a passion for scientific discovery, Myokardia's team of researchers and scientists are dedicated to advancing the field of medicine. Through their commitment to global inclusion and diversity, they aim to close the diversity gap in clinical trials and ensure that all patients have access to the best possible treatments. With a strong emphasis on sustainability and responsibility, Myokardia is committed to making a positive impact on the world and improving the lives of patients worldwide.
Generated from the website